Loading...
Loading...
In medical devices, import or manufacturing, you must acquire approval from the Drug Controller General of India (DCGI). With India's reputable position in the global healthcare industry, the approval of DCGI is of supreme importance for the Indian markets to function effectively.
About the Author
Hansika Bhardwaj is a versatile writer, editor and poet. She is a graduate of the University of Delhi with a specialisation in English Literature. As a cherry on the cake, she has worked with various companies dealing with various types of content, from technical to creative. She can view a rather mundane topic from a creative lens by turning jargon into readable material. Currently, she is working at Corpseed as a content writer and is all set to embark on this learning journey.
Related articles
CDSCO Mandates ONDLS Portal for r-DNA Drug License Applications
2026-03-16
New Drug Manufacturing and Clinical Trial Rules Updated in 2026: What You Should Know?
2026-03-13
CDSCO Releases New Guidelines for Compounding of Offences Under the Drugs and Cosmetics Act
2026-02-26
Regulation of Medical Device Pricing and Quality in India: Key Government Measures
2026-02-20
CDSCO Releases Risk Classification List for Oncology Medical Devices
2026-02-12
Government Notifies CGHS Drug Procurement Policy 2026
2026-01-24
What Is BRC in Export? e-BRC Process, Self-Certification & DGFT Filing Guide 2026
2026-03-26 • 0 views
2023-02-27
India Extends CBG-CGD Scheme Till 2047 to Boost Clean Energy and Cut Import Dependence
2026-03-24
.png&w=1536&q=75)
